drug
ferric maltol
Marketedupdated 3mo agoby Shield TX (UK) Ltd
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3all catalysts(6)
approval · 6
Jul 25, 2019
approval
ACCRUFER (FERRIC MALTOL) — FDA approval
ferric maltol
→
Oct 28, 2020
approval
ACCRUFER (FERRIC MALTOL) — FDA approval
ferric maltol
→
Feb 16, 2022
approval
ACCRUFER (FERRIC MALTOL) — FDA approval
ferric maltol
→
Jun 1, 2022
approval
ACCRUFER (FERRIC MALTOL) — FDA approval
ferric maltol
→
Sep 8, 2022
approval
ACCRUFER (FERRIC MALTOL) — FDA approval
ferric maltol
→
Dec 19, 2025
approval
ACCRUFER (FERRIC MALTOL) — FDA approval
ferric maltol
→
Trials studying ferric maltol
- phase4Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women
- phase3Perioperative Iron for Colorectal Cancer (PICoC Study)
- phase3Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
- phase1Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers
- phase4ORal IrON Supplementation with Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients with Heart Failure (ORION-HF)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 19, 2028
~2.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Oct 23, 2035compositionUS 9802973
- Jan 6, 2035method-of-use (U-2603)US 10179120
- Mar 29, 2031method-of-use (U-2603)US 92481484.6y
FDA exclusivities (1)
- Dec 19, 2028NPPNew Product (3y)2.4y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 58m ago
Found something off?
comments(0)
5-min edit window · permanent after that